Genelux
durable survival benefit | Genelux
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
14 of 37
Similar slides by Genelux
See diffirences between slides (animation)
Investor Presentation
December 2023
durable survival benefit | Genelux
Investor Presentation
October 2023
durable benefit of overall survival via clinically validated | Genelux
Investor Presentation
July 2023
durable benefit of overall survival via clinically validated | Genelux
Related slides by other companies
Immix Biopharma
Investor Presentation
November 2023
clinical data month in late stage sarcoma well tolerated oat immix | Immix Biopharma
Aeglea BioTherapeutics
Investor Presentation
August 2020
demonstrates durable clinical response at week analysis | Aeglea BioTherapeutics
First Republic Bank
Investor Day
November 2022
the bottom line strong long term performance bank | First Republic Bank
Immix Biopharma
Investor Presentation
August 2023
clinical data month in late stage sarcoma well tolerated oat immix | Immix Biopharma
Other recent decks by Genelux
See all presentations (4 decks)
Investor Presentation
December 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io